Madrigal Pharmaceuticals, Inc. (MDGL)
542.43
-4.50
(-0.82%)
USD |
NASDAQ |
Sep 03, 15:41
Madrigal Pharmaceuticals Net Income (Annual) : -288.28M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -288.28M |
| December 31, 2024 | -465.89M |
| December 31, 2023 | -373.63M |
| December 31, 2022 | -295.35M |
| December 31, 2021 | -241.85M |
| December 31, 2020 | -202.24M |
| December 31, 2019 | -83.95M |
| December 31, 2018 | -32.81M |
| December 31, 2017 | -31.15M |
| December 31, 2016 | -26.39M |
| December 31, 2015 | -6.845M |
| December 31, 2014 | -86.16M |
| Date | Value |
|---|---|
| December 31, 2013 | -90.19M |
| December 31, 2012 | -62.79M |
| December 31, 2011 | -47.38M |
| December 31, 2010 | -37.47M |
| December 31, 2009 | 79.09M |
| December 31, 2008 | -92.62M |
| December 31, 2007 | -63.50M |
| December 31, 2006 | -57.27M |
| December 31, 2005 | -68.86M |
| December 31, 2004 | -45.93M |
| December 31, 2003 | -27.88M |
| December 31, 2002 | -36.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Exelixis, Inc. | 782.57M |
| Karyopharm Therapeutics, Inc. | -196.04M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |